Indeed, Akt is frequently activated in human cancers (reviewed in [45]) and its hyper-activation (directly by over-expression or mutation, or indirectly through alterations to PTEN) offers protection against apoptosis and at least in part promotes cell-cycle progression [46], which are two major hallmarks of cancer [35,47]. This evidence concerns the gene AKT1 and cancer.